日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Lenvatinib plus Pembrolizumab for Patients with Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results from the Phase II LEAP-005 Study

乐伐替尼联合帕博利珠单抗治疗既往接受过治疗的晚期胃癌、胆道癌或胰腺癌患者:II期LEAP-005研究结果

Ponz-Sarvisé, Mariano; Rha, Sun Young; Gomez-Roca, Carlos A; Ortega Morán, Laura; Gill, Sanjeev; Tortora, Giampaolo; Geva, Ravit; Saada-Bouzid, Esma; Santoro, Armando; Kim, Tae Won; Heudobler, Daniel; Dutcus, Corina E; Okpara, Chinyere E; Ghori, Razi; Zhang, Yiwei; Vajdi, Amir; Dettman, E J; Jin, Fan; Groisberg, Roman; Shapira-Frommer, Ronnie

Lenvatinib plus pembrolizumab for patients with previously treated select solid tumors: Results from the phase 2 LEAP-005 study recurrent glioblastoma cohort

乐伐替尼联合帕博利珠单抗治疗既往接受过治疗的特定实体瘤患者:来自 LEAP-005 II 期研究复发性胶质母细胞瘤队列的结果

Rha, Sun Young; Castanon, Eduardo; Gill, Sanjeev; Senellart, Helene; Lopez, Juanita; Márquez-Rodas, Iván; Victoria, Iván; Kim, Tae Min; Lwin, Zarnie; Burger, Michael C; Simonelli, Matteo; Cassier, Philippe A; Hendifar, Andrew E; Ascierto, Paolo A; Dutcus, Corina; Okpara, Chinyere E; Ghori, Razi; Jin, Fan; Groisberg, Roman; Villanueva, Luis

Evaluation of potential biomarkers for lenvatinib plus pembrolizumab among patients with advanced endometrial cancer: results from Study 111/KEYNOTE-146

评估乐伐替尼联合帕博利珠单抗治疗晚期子宫内膜癌患者的潜在生物标志物:111/KEYNOTE-146 研究结果

Makker, Vicky; Taylor, Matthew H; Aghajanian, Carol; Cohn, Allen L; Brose, Marcia S; Simone, Christopher Di; Cao, Zhu Alexander; Suttner, Leah; Loboda, Andrey; Cristescu, Razvan; Jelinic, Petar; Orlowski, Robert; Dutta, Lea; Matsui, Junji; Dutcus, Corina E; Minoshima, Yukinori; Messing, Mark J

A Phase Ib/II Study of Lenvatinib and Pembrolizumab in Advanced Endometrial Carcinoma (Study 111/KEYNOTE-146): Long-Term Efficacy and Safety Update

乐伐替尼联合帕博利珠单抗治疗晚期子宫内膜癌的 Ib/II 期研究(研究 111/KEYNOTE-146):长期疗效和安全性更新

Makker, Vicky; Aghajanian, Carol; Cohn, Allen L; Romeo, Margarita; Bratos, Raquel; Brose, Marcia S; Messing, Mark; Dutta, Lea; Dutcus, Corina E; Huang, Jie; Schmidt, Emmett V; Orlowski, Robert; Taylor, Matthew H

A Randomized Study of Lenvatinib 18 mg vs 24 mg in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer

一项随机研究比较了乐伐替尼 18 mg 与 24 mg 治疗放射性碘难治性分化型甲状腺癌患者的疗效

Brose, Marcia S; Panaseykin, Yury; Konda, Bhavana; de la Fouchardiere, Christelle; Hughes, Brett G M; Gianoukakis, Andrew G; Joo Park, Young; Romanov, Ilia; Krzyzanowska, Monika K; Leboulleux, Sophie; Binder, Terri A; Dutcus, Corina; Xie, Ran; Taylor, Matthew H

Lenvatinib dose, efficacy, and safety in the treatment of multiple malignancies

乐伐替尼在多种恶性肿瘤治疗中的剂量、疗效和安全性

Motzer, Robert J; Taylor, Matthew H; Evans, Thomas R Jeffry; Okusaka, Takuji; Glen, Hilary; Lubiniecki, Gregory M; Dutcus, Corina; Smith, Alan D; Okpara, Chinyere E; Hussein, Ziad; Hayato, Seiichi; Tamai, Toshiyuki; Makker, Vicky

Pharmacodynamic Biomarkers Predictive of Survival Benefit with Lenvatinib in Unresectable Hepatocellular Carcinoma: From the Phase III REFLECT Study

预测乐伐替尼治疗不可切除肝细胞癌患者生存获益的药效学生物标志物:来自 III 期 REFLECT 研究

Finn, Richard S; Kudo, Masatoshi; Cheng, Ann-Lii; Wyrwicz, Lucjan; Ngan, Roger K C; Blanc, Jean-Frederic; Baron, Ari D; Vogel, Arndt; Ikeda, Masafumi; Piscaglia, Fabio; Han, Kwang-Hyub; Qin, Shukui; Minoshima, Yukinori; Kanekiyo, Michio; Ren, Min; Dairiki, Ryo; Tamai, Toshiyuki; Dutcus, Corina E; Ikezawa, Hiroki; Funahashi, Yasuhiro; Evans, Thomas R Jeffry

Correlative serum biomarker analyses in the phase 2 trial of lenvatinib-plus-everolimus in patients with metastatic renal cell carcinoma

在转移性肾细胞癌患者中,乐伐替尼联合依维莫司治疗的II期临床试验中,血清生物标志物相关性分析

Lee, Chung-Han; Motzer, Robert J; Glen, Hilary; Michaelson, M D; Larkin, James; Minoshima, Yukinori; Kanekiyo, Michio; Ikezawa, Hiroki; Sachdev, Pallavi; Dutcus, Corina E; Funahashi, Yasuhiro; Voss, Martin H

Correlation of Performance Status and Neutrophil-Lymphocyte Ratio with Efficacy in Radioiodine-Refractory Differentiated Thyroid Cancer Treated with Lenvatinib

功能状态和中性粒细胞-淋巴细胞比值与接受乐伐替尼治疗的放射性碘难治性分化型甲状腺癌疗效的相关性

Taylor, Matthew H; Takahashi, Shunji; Capdevila, Jaume; Tahara, Makoto; Leboulleux, Sophie; Kiyota, Naomi; Dutcus, Corina E; Xie, Ran; Robinson, Bruce; Sherman, Steven; Habra, Mouhammed Amir; Elisei, Rossella; Wirth, Lori J

Safety and efficacy of lenvatinib by starting dose based on body weight in patients with unresectable hepatocellular carcinoma in REFLECT

REFLECT 研究评估了根据体重调整起始剂量的乐伐替尼治疗不可切除肝细胞癌患者的安全性和有效性

Okusaka, Takuji; Ikeda, Kenji; Kudo, Masatoshi; Finn, Richard; Qin, Shukui; Han, Kwang-Hyub; Cheng, Ann-Lii; Piscaglia, Fabio; Kobayashi, Masahiro; Sung, Max; Chen, Minshan; Wyrwicz, Lucjan; Yoon, Jung-Hwan; Ren, Zhenggang; Mody, Kalgi; Dutcus, Corina; Tamai, Toshiyuki; Ren, Min; Hayato, Seiichi; Kumada, Hiromitsu